Last reviewed · How we verify
Inactivated rabies virus vaccine — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Inactivated rabies virus vaccine (Inactivated rabies virus vaccine) — Sanofi Pasteur, a Sanofi Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Inactivated rabies virus vaccine TARGET | Inactivated rabies virus vaccine | Sanofi Pasteur, a Sanofi Company | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Inactivated rabies virus vaccine CI watch — RSS
- Inactivated rabies virus vaccine CI watch — Atom
- Inactivated rabies virus vaccine CI watch — JSON
- Inactivated rabies virus vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Inactivated rabies virus vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/inactivated-rabies-virus-vaccine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab